Detailed answers about BIOVERITAS MEDICAL COMMUNICATIONS LIMITED, including incorporation, status, business activity, and accounts information.
When was BIOVERITAS MEDICAL COMMUNICATIONS LIMITED founded?
BIOVERITAS MEDICAL COMMUNICATIONS LIMITED was officially incorporated on 2 March 2026 and is registered under company number 17063435. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BIOVERITAS MEDICAL COMMUNICATIONS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of BIOVERITAS MEDICAL COMMUNICATIONS LIMITED?
BIOVERITAS MEDICAL COMMUNICATIONS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does BIOVERITAS MEDICAL COMMUNICATIONS LIMITED do?
BIOVERITAS MEDICAL COMMUNICATIONS LIMITED operates in the following sector: 74909 - Other professional, scientific and technical activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is BIOVERITAS MEDICAL COMMUNICATIONS LIMITED's registered address?
The registered office address of BIOVERITAS MEDICAL COMMUNICATIONS LIMITED is 167-169 Great Portland Street, London, England, W1W 5PF. This is the official address filed with Companies House for legal and statutory correspondence.
Is BIOVERITAS MEDICAL COMMUNICATIONS LIMITED financially stable?
Financial accounts for BIOVERITAS MEDICAL COMMUNICATIONS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.